Literature DB >> 10853865

Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis.

S Cunningham1, J R McColm, L P Ho, A P Greening, T G Marshall.   

Abstract

Identifying noninvasive markers of pulmonary inflammation would be useful in assessing new therapies in children. Breath condensate is a simple and potentially acceptable sample medium even in small children. The technique has previously been used in adults, but not children with cystic fibrosis. The technique was assessed in 36 children with cystic fibrosis (mean age 10.4 yrs) and 17 control subjects, analysing samples for nitrite, interleukin(IL)-8 and salivary and nasal contamination. Correlations were made between levels of the inflammatory markers and forced expiratory volume in one second/forced vital capacity, chest radiograph score and use of inhaled steroids. On samples without significant contamination (<10 u x L(-1) amylase) nitrite was detected in 93% of samples at a median concentration of 3.0 microM compared with 50% of control samples at a median of 0.5 microM. Condensate amylase levels did not correlate with the nitrite value obtained (r=0.31). IL-8 was detected in 33% of CF samples. Breath condensate is an acceptable method of sample collection in children. Nitrite was raised in breath condensate from patients with cystic fibrosis when compared with control subjects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853865     DOI: 10.1034/j.1399-3003.2000.15e24.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

Review 1.  Monitoring inflammation in CF. Cytokines.

Authors:  Scott D Sagel; Frank J Accurso
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

2.  Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation.

Authors:  H Marteus; D C Törnberg; E Weitzberg; U Schedin; K Alving
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

3.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

Review 4.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

5.  Safety and success of exhaled breath condensate collection in asthma.

Authors:  E Baraldi; L Ghiro; V Piovan; S Carraro; F Zacchello; S Zanconato
Journal:  Arch Dis Child       Date:  2003-04       Impact factor: 3.791

6.  Effects of wood smoke particles from wood-burning stoves on the respiratory health of atopic humans.

Authors:  Ingunn Skogstad Riddervold; Jakob Hjort Bønløkke; Anna-Carin Olin; Therese Koops Grønborg; Vivi Schlünssen; Kristin Skogstrand; David Hougaard; Andreas Massling; Torben Sigsgaard
Journal:  Part Fibre Toxicol       Date:  2012-04-30       Impact factor: 9.400

Review 7.  Exhaled Breath Condensate: Technical and Diagnostic Aspects.

Authors:  Efstathia M Konstantinidi; Andreas S Lappas; Anna S Tzortzi; Panagiotis K Behrakis
Journal:  ScientificWorldJournal       Date:  2015-05-27

8.  Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD.

Authors:  Jean Louis Corhay; Catherine Moermans; Monique Henket; Delphine Nguyen Dang; Bernard Duysinx; Renaud Louis
Journal:  Respir Res       Date:  2014-09-28

9.  Toward point-of-care management of chronic respiratory conditions: Electrochemical sensing of nitrite content in exhaled breath condensate using reduced graphene oxide.

Authors:  Azam Gholizadeh; Damien Voiry; Clifford Weisel; Andrew Gow; Robert Laumbach; Howard Kipen; Manish Chhowalla; Mehdi Javanmard
Journal:  Microsyst Nanoeng       Date:  2017-05-22       Impact factor: 7.127

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.